Fuchs' dystrophy,
also known as Fuchs' endothelial dystrophy, is a slowly progressing corneal
disease that usually affects both eyes and is slightly more common in women
than in men. Although doctors can often see early signs of Fuchs' dystrophy
in people in their 30s and 40s, the disease rarely affects vision until
people reach their 50s and 60s.
The condition was first described by Austrian Ernst Fuchs (1851-1930),
for whom it is named.
Etiology
Fuchs' dystrophy occurs when endothelial cells gradually deteriorate
without any apparent reason. As more endothelial cells are lost over the
years, the endothelium becomes less efficient at pumping water out of
the stroma. This causes the cornea to swell and distort vision. Eventually,
the epithelium also takes on water, resulting in pain and severe visual
impairment.
Epithelial swelling damages vision by changing the cornea's normal
curvature, and causing a sight-impairing haze to appear in the tissue.
Epithelial swelling will also produce tiny blisters on the corneal surface.
When these blisters burst, they are extremely painful.
Signs and Symptoms
At first, a person with Fuchs' dystrophy will awaken with blurred
vision that will gradually clear during the day. This occurs because the
cornea is normally thicker in the morning; it retains fluids during sleep
that evaporate in the tear film while we are awake. As the disease worsens,
this swelling will remain constant and reduce vision throughout the day.
Treatment
When treating the disease, doctors will try first to reduce the
swelling with drops, ointments, or soft contact lenses. They also may
instruct a person to use a hair dryer, held at arm's length or directed
across the face, to dry out the epithelial blisters. This can be done
two or three times a day.
When the disease interferes with daily activities, a person may
need to consider having a corneal transplant to restore sight. The short-term
success rate of corneal transplantation is quite good for people with
Fuchs' dystrophy. However, some studies suggest that the long-term survival
of the new cornea can be a problem.